Trials / Unknown
UnknownNCT03982290
Psychophysiological Effects of Lactobacillus Plantarum PS128 in Preschool Children With Autism Spectrum Disorder
Psychophysiological Effects of Lactobacillus Plantarum PS128 in Preschool Children With Autism Spectrum Disorder: a Randomized, Placebo-controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Mackay Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 30 Months – 7 Years
- Healthy volunteers
- Accepted
Summary
Autism Spectrum Disorders (ASD) comprises a complex group of disorders of neuronal development characterized by social and communication impairment along with presence of repetitive and restrictive behaviors. Emerging evidences support the gut-brain axis and further microbiota-gut-brain axis. Elevated prevalence of gastrointestinal (GI) dysfunction in individuals with ASD suggested that targeting gut may benefit patients with ASD. Lactobacillus plantarum PS128 (PS128) was reported to be a psychobiotic in several animal studies which modulated the levels of neurotransmitters in different brain areas. The current randomized, placebo-controlled trial was conducted to investigate the psychophysiological effects of PS128 in preschool children with ASD.
Detailed description
Emerging evidences support the gut-brain axis and further microbiota-gut-brain axis. Elevated prevalence of gastrointestinal (GI) dysfunction in individuals with ASD suggested that targeting gut may benefit patients with ASD. Lactobacillus plantarum PS128 (PS128) was reported to be a psychobiotic in several animal studies which modulated the levels of neurotransmitters in different brain areas. The current randomized, placebo-controlled trial was conducted to investigate the psychophysiological effects of PS128 in preschool children with ASD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Probiotic, Lactobacillus plantarum PS128 | PS128 capsules, 2 capsules per day |
| OTHER | Placebo, microcrystalline cellulose | Placebo capsules, 2 capsules per day |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2019-12-01
- Completion
- 2020-12-01
- First posted
- 2019-06-11
- Last updated
- 2019-06-11
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03982290. Inclusion in this directory is not an endorsement.